Cross-sensitization between caffeine- and l-dopa-induced behaviors in hemiparkinsonian mice
@article{Yu2006CrosssensitizationBC, title={Cross-sensitization between caffeine- and l-dopa-induced behaviors in hemiparkinsonian mice}, author={L. Yu and M. Schwarzschild and J. Chen}, journal={Neuroscience Letters}, year={2006}, volume={393}, pages={31-35} }
Adenosine A(2A) receptor (A(2A)R) antagonists, including the non-specific adenosine antagonist caffeine, have been proposed as a novel, non-dopaminergic treatment strategy for Parkinson's disease (PD). However, the long-term interaction between caffeine and L-dopa treatment in PD models has not been characterized. We examined the interaction between caffeine and L-dopa following a repeated treatment paradigm in hemiparkinsonian mice. In contrast to the progressively sensitized rotational… CONTINUE READING
Topics from this paper
18 Citations
Caffeine and a selective adenosine A2A receptor antagonist induce sensitization and cross-sensitization behavior associated with increased striatal dopamine in mice
- Chemistry, Medicine
- Journal of Biomedical Science
- 2009
- 38
Neuroprotective effects of caffeine in the model of 6-hydroxydopamine lesion in rats
- Medicine
- Pharmacology Biochemistry and Behavior
- 2006
- 64
Co-administration of the partial dopamine D2 agonist terguride with L-dopa attenuates L-dopa-induced locomotor sensitization in hemiparkinsonian mice
- Chemistry, Medicine
- Behavioural Brain Research
- 2009
- 8
Interactions between adenosine and dopamine receptor antagonists with different selectivity profiles: Effects on locomotor activity
- Chemistry, Medicine
- Behavioural Brain Research
- 2010
- 46
Sustained improvement of motor function in hemiparkinsonian rats chronically treated with low doses of caffeine or trihexyphenidyl
- Medicine
- Pharmacology Biochemistry and Behavior
- 2007
- 11
Deletion of adenosine A1 or A2A receptors reduces l-3,4-dihydroxyphenylalanine-induced dyskinesia in a model of Parkinson's disease
- Biology, Medicine
- Brain Research
- 2011
- 38
The effects of systemic, intrastriatal, and intrapallidal injections of caffeine and systemic injections of A2A and A1 antagonists on forepaw stepping in the unilateral 6-OHDA-lesioned rat
- Medicine
- Psychopharmacology
- 2008
- 27
- Highly Influenced
Caffeine Protects Dopaminergic Neurons From Dopamine-Induced Neurodegeneration via Synergistic Adenosine-Dopamine D2-Like Receptor Interactions in Transgenic Caenorhabditis elegans
- Chemistry, Medicine
- Front. Neurosci.
- 2018
- 16
- PDF
Protective effects of the caffeine against neurodegenerative diseases.
- Medicine
- Current medicinal chemistry
- 2017
- 11
References
SHOWING 1-10 OF 32 REFERENCES
Cross-sensitization between the motor activating effects of bromocriptine and caffeine: role of adenosine A2A receptors
- Chemistry, Medicine
- Behavioural Brain Research
- 2000
- 26
Caffeine cross-tolerance to selective dopamine D1 and D2 receptor agonists but not to their synergistic interaction.
- Chemistry, Medicine
- European journal of pharmacology
- 1994
- 49
Persistent Behavioral Sensitization to Chronic l-DOPA Requires A2A Adenosine Receptors
- Medicine
- The Journal of Neuroscience
- 2002
- 127
- PDF
Subchronic caffeine administration sensitizes rats to the motor-activating effects of dopamine D1 and D2 receptor agonists
- Chemistry, Medicine
- Psychopharmacology
- 2002
- 30
Absence of the adenosine A2A receptor or its chronic blockade decrease ethanol withdrawal-induced seizures in mice
- Medicine
- Neuropharmacology
- 2001
- 76
A Crucial Role for Forebrain Adenosine A2A Receptors in Amphetamine Sensitization
- Psychology, Medicine
- Neuropsychopharmacology
- 2005
- 91
- PDF
Caffeine withdrawal syndrome in social interaction test in mice: Effects of the NMDA receptor channel blockers, memantine and neramexane
- Medicine, Psychology
- Behavioural pharmacology
- 2004
- 12
Caffeine's neuroprotection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity shows no tolerance to chronic caffeine administration in mice
- Chemistry, Medicine
- Neuroscience Letters
- 2002
- 94
Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys
- Medicine
- Neurology
- 1999
- 243
Caffeine treatment and withdrawal in mice: relationships between dosage, concentrations, locomotor activity and A1 adenosine receptor binding.
- Chemistry, Medicine
- The Journal of pharmacology and experimental therapeutics
- 1993
- 74